Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be negatively ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

Getinge's quarterly earnings beat market expectations on Friday, driven by organic sales growth across its business areas and regions, as the medical equipment maker seeks ways beyond pricing to ...

US President Donald Trump has said that he will impose 10-15% tariff on more than 150 countries. He also said that this ...

Johnson & Johnson (NYSE:JNJ) is one of the Most Undervalued High Quality Stocks to Buy According to Hedge Funds. On July 10, ...

Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, and the government's foreign aid freeze.

India and the US are key trade partners, but a formal trade deal is still missing. As talks progress, the big question is: ...

President Trump threatens to raise tariffs, claiming the European Union won't buy U.S. cars or food — but 2024 trade data shows otherwise.

TSMC's 30% growth is driven by soaring AI and HPC chip demand. Click to read more on my updated look at TSM and its Q2 ...